Compare Camtek (CAMT) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Camtek vs Tenet Healthcare Corporation — how do they compare? Camtek trades at $149.12 (market cap $6.96B), while Tenet Healthcare Corporation trades at $261.99 (market cap $21.10B). The key difference: Tenet Healthcare Corporation is far larger — about 3× Camtek's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Camtek nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Camtek for 1 Days and Tenet Healthcare Corporation for 14 Days on average.
| CAMT | THC | |
|---|---|---|
Market Cap | $6.96B | $21.10B |
Volume | 177,164 | 3,183,957 |
Sector | Technology | Health |
52-Week High | $207.46 | $280.77 |
52-Week Low | $94.40 | $161.37 |
Typical Hold Time | 1 Days | 14 Days |
Enterprise Value | $6.82B | $32.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CAMT trades at $149.12, up 3.4% with a neutral technical signal. The stock shows strong analyst support with 10 buy ratings and a $181.50 consensus target, representing 22% upside. Recent Q2 2026 earnings beat expectations with record $133.2M revenue, though valuation metrics appear elevated with P/E at 201.5 and P/S at 14.95. The company expects over 30% growth in H2 2026 versus H1 2026, driven by AI-driven semiconductor packaging demand.
CAMT presents growth potential from AI semiconductor tailwinds but carries valuation and execution risks. The stock's premium multiples require sustained high growth, while CEO share sales and competitive pressures warrant monitoring. Near-term catalysts include Q3 earnings and H2 growth realization, but investors should balance optimism with valuation discipline given the stretched metrics.
Tenet Healthcare (THC) trades at $261.99 with minimal daily movement (+0.03%). The stock shows strong fundamentals with consistent earnings beats, robust profitability (ROE 53.31%), and attractive valuation (P/E 10.13). Technical indicators are neutral overall, with the price near the pivot point of $263. Recent news highlights insider selling but positive analyst coverage with 81% buy ratings.
Outlook remains positive given earnings momentum and sector demand, though risks include debt refinancing activity and insider sales. The consensus price target of $284.77 suggests ~9% upside potential, supported by strong hospital operator trends and efficient operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Camtek
Camtek develops inspection and metrology systems for semiconductor manufacturing. Its equipment is used to identify defects and measure process performance, including in advanced packaging.
Read more on CAMT →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
